Rebus Medical Ltd’s Post

Some interesting insights from the Rebus Medical Ltd team about human factors activities both before and during clinical trails for Medical Devices. Have a read of our peer-reviewed article in the Journal of Medical Engineering & Technology. #HumanFactors #MedicalDevices

FasterCures has been at the forefront of the 21st Century Cures Act from its development, enactment, and implementation, and demonstrating our long-term commitment to biomedical innovation. FasterCures shared recommendations for the next scientific and research advancement by Cures 2.0. Key recommendations include: ◾ Building infrastructure for community-based clinical research ◾ Enhancing FDA-CMS collaboration for seamless approval and access to medical products ◾ Strengthening patient engagement in medical product development ◾ Aligning evidentiary requirements between the FDA and CMS for timely patient access ◾ Upholding ACA preventive care provisions and establishing heightened focus on prevention ◾ Continuous funding for innovative research programs that fill the gaps of biomedical innovation Read the full comment letter here: https://lnkd.in/esJ2jS4c

Analysis of five HTAs of medical technologies in 2023 and strategic recommendations for evidence generation strategy in England. Health technology assessment plays an important role in market access for medical technologies in England. National Institute for Health and Care Excellence (NICE) is the key HTA organization with several programs dedicated to the assessment of medical technologies. One of the key med tech-related programs at NICE is the Interventional Procedures Program. The evidence requirements in the program are not entirely clear and depend on many factors (population, level of unmet need, level of invasiveness, safety profile, and many others). MTRC developed an analytical White Paper with review of five recent assessments by NICE to present the evidence requirements for medical technologies in this particular HTA program. A review of five cases is followed by recommendations in relation to evidence generation for medical technologies, market access in England, and factors influencing the decision-making of NICE. Request an analytical White Paper here: https://lnkd.in/ersEsFnq

Did you know there are over 498,000 clinical trials happening worldwide in 2024? 🌎 Discover how these studies are transforming healthcare and advancing medical science! #ClinicalTrials #MedicalResearch #HealthcareInnovation #CareTrials https://lnkd.in/gBGudjq6

A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research https://lnkd.in/de4HipWq Traditional medical research infrastructures relying on the Centers of Excellence (CoE) model (an infrastructure or shared facility providing high standards of research excellence and resources to advance scie...

🤔 Curious about how patient-generated health data (PGHD) can enhance medical device development? 📅 Join us at the FREE public meeting led by FDA and Digital Medicine Society (DiMe) on June 26, 11 a.m. – 3 p.m. ET, and June 27, 11 a.m. – 3 p.m. ET. Together, we’ll explore how PGHD can advance remote clinical trial #data collection and facilitate high-quality clinical outcome assessment. You will have the opportunity to learn about and discuss: ▪️ How to implement PGHD throughout the total product life cycle development of medical device development ▪️ Tangible case examples of how PGHD has informed medical devices and can improve return on investment ▪️ How PGHD can help improve health equity by promoting inclusivity in research studies ▪️ Case-based learning on the use of PGHD for medical device developers, scientists, and patients Don’t miss out! Register today for this unique opportunity to learn alongside industry leaders and contribute to future work on resources to advance the use of PGHD in clinical #research and regulatory science. 🔗 https://bit.ly/3K38K55

We know that planning your attendance at scientific and medical conferences can be overwhelming with so many presentations and speakers. Now, there’s a better way to navigate these events and we're so excited to offer it to our clients in life sciences starting today... 🌟 Introducing Monocl Conferences—your on-demand platform for powerful conference insights! 🌟 With Monocl Conferences, teams in medical affairs, marketing, and conference planning can easily access rich, contextualized data and connect with the experts driving conference activities. Stay informed about sessions, speakers, abstracts, timings, and more—all in one convenient place. Simplify your conference planning and enhance your KOL engagement with the insights you need right at your fingertips.  👉 See how Monocl Conferences makes conference planning a breeze for life science organizations. Learn more below! ✔ Book a demo > https://bit.ly/3BJSR2i  ✔ Visit web page > https://bit.ly/4dUq4Wa  ✔ Read press release > https://bit.ly/3NtBa9T #BetterConferencePlanning #BetterEngagement #DHLifeSciences  

The Power of Clinical Research: Science Shaping the Future! May 20th is celebrated as International Clinical Trials Day. This day commemorates James Lind, who is recognized for conducting the first controlled clinical trial in 1747. Lind's work laid the foundation for modern clinical research and demonstrated the importance of systematic testing in medical practice. By comparing the effects of different treatments on sailors suffering from scurvy, he established a scientific method that continues to guide clinical trials today. International Clinical Trials Day aims to highlight the crucial role of clinical research in advancing medical knowledge and improving patient care. It underscores the importance of clinical trials in developing new treatments, medications, and health technologies. By raising awareness, the day seeks to inform the public about the benefits and processes of clinical research, promoting greater understanding and participation in clinical trials. Additionally, this day is an opportunity to recognize and appreciate the contributions of patients who participate in clinical trials, as well as the healthcare professionals and researchers who conduct these studies. Events and seminars held worldwide on this day focus on educating the public about the ethical standards, safety protocols, and significance of clinical trials in bringing innovative healthcare solutions to the market. #ClinicalTrialsDay #WorldClinicalTrialsDay #ClinicalResearch #MedicalResearch #JamesLind #InnovativeHealthcare #MedicalAdvancements #ClinicalTrials #ResearchMatters #HealthcareInnovation #PatientCare #ClinicalStudies #HealthResearch #Fibula #FibulaHEALTH #FibulaCRO #FibulaResearch

The impact of publications on clinical practice is huge. However, the pain point for any publication is 'shelf life'... 👀 Attention for what could be a game-changing bit of medical research wanes quickly given the speed at which data is published in the medical universe. 🔊 Extending the shelf-life through amplification to maximise reach and impact is paramount to ensure your publications are seen. 👇 Please read this article - if you see something in there that you want to discuss with me, drop me a PM #Medicalaffairs #Medcomms #Solli #Medscape